Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
February 08, 2024 09:55 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 8 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
February 06, 2024 13:43 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 6 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S - share repurchase programme
February 06, 2024 02:20 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 6 February 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion will be initiated on 6 February 2024. As part of this, Novo...
Novo Nordisk to acquire three fill-finish sites from Novo Holdings A/S in connection with the Catalent, Inc. transaction
February 05, 2024 06:04 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 5 February 2024 – Novo Nordisk today announced that the company has agreed to acquire three fill-finish sites from Novo Holdings A/S (Novo Holdings) in connection with a transaction...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
February 01, 2024 14:51 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 1 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk files annual report with the SEC
January 31, 2024 07:34 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 31 January 2024 – Novo Nordisk A/S has filed its Annual Report 2023 on Form 20-F for the financial year 2023 with the US Securities and Exchange Commission (SEC), incorporating by...
Novo Nordisk's sales increased by 31% in Danish kroner and by 36% at constant exchange rates to DKK 232.3 billion in 2023
January 31, 2024 01:30 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 31 January 2024 - Financial report for the period 1 January 2023 to 31 December 2023 ...
Novo Nordisk A/S - share repurchase programme
January 30, 2024 10:28 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 30 January 2024 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
January 22, 2024 07:01 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 22 January 2024 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
January 15, 2024 05:43 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 January 2024 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...